July 2020 FDA Recall Drug by Sca Pharmaceuticals
D-1495-2020 - Subpotent Drug

This Class II drug recall was voluntarily initiated by Sca Pharmaceuticals on July 29, 2020 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1495-2020

Reason for Recall
Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.
Initiated
07-29-2020
Reported
08-19-2020
Quantity
3,932 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Product was distributed nationwide within the United States.
Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), Rx only, SCA Pharmaceuticals 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0650-46

Batch or Lot Expiration Information

Lot# : 1220018755, Exp. Date 7/30/2020; 1220018861, 1220018850, Exp. Date 8/4/2020; 1220018899, Exp. Date 8/5/2020; 1220019027, Exp. Date 8/11/2020; 1220019075, Exp. Date 8/12/2020; 1220019243, Exp. Date 8/20/2020; 1220019439, 1220019279, 1220019392, Exp. Date 8/24/2020; 1220019488, Exp. Date 8/26/2020